GASTROESOPHAGEAL JUNCTION
Clinical trials for GASTROESOPHAGEAL JUNCTION explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL JUNCTION trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL JUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for stomach cancer patients: experimental drug combos enter trial
Disease control Recruiting nowThis study tests two new drug combinations for people with advanced stomach, gastroesophageal junction, or esophageal cancer that has worsened after initial treatment. About 210 participants will receive either an experimental antibody-drug conjugate plus standard chemotherapy, o…
Matched conditions: GASTROESOPHAGEAL JUNCTION
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 09:00 UTC
-
New hope for hard-to-treat stomach cancer: experimental drug combo enters phase 2
Disease control Recruiting nowThis study tests a new drug called denikitug, either alone or with other treatments, for people with advanced HER2-negative stomach, gastroesophageal junction, or esophageal cancer that has spread or come back. About 120 participants will be randomly assigned to different treatme…
Matched conditions: GASTROESOPHAGEAL JUNCTION
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated May 26, 2026 08:56 UTC
-
New hope for stomach cancer: experimental drug cocktail enters human trials
Disease control Recruiting nowThis study tests whether adding new investigational drugs to standard chemotherapy and immunotherapy (pembrolizumab) can safely shrink tumors in people with advanced stomach, gastroesophageal junction, or esophageal cancer that has not been treated before. About 160 adults whose …
Matched conditions: GASTROESOPHAGEAL JUNCTION
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New imaging agent could sharpen cancer staging for stomach and esophageal tumors
Diagnosis Recruiting nowThis study tests a new type of PET scan called [¹⁸F]FAPI-74 to see if it can more accurately detect whether stomach or esophageal cancer has spread to other parts of the body. About 200 adults with these cancers will receive one dose of the imaging agent and then be scanned. The …
Matched conditions: GASTROESOPHAGEAL JUNCTION
Phase: PHASE3 • Sponsor: SOFIE • Aim: Diagnosis
Last updated May 26, 2026 08:33 UTC